Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab (KN026) were Published in Annals of Oncology
SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (stock code:...
ICP DAS-BMP at WHX Dubai 2026 Spotlights Low-Migration and Low-Friction TPU
HSINCHU, Jan. 27, 2026 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation in WHX Dubai 2026 (formerly Arab Health), taking place from 9 to 12 February at the Dubai Exhibition Centre. Visitors can find the ICP DAS-BMP...
New “MedTech Advance” Sourcing Directory Launches to Streamline Global Medical Device Manufacturing
Comprehensive e-book accelerates product development by connecting R&D and procurement teams with global suppliers. TAICHUNG, Jan. 27, 2026 /PRNewswire/ -- Today marks the official release of MedTech Advance, a comprehensive digital buyer's directory engineered to accelerate the sourcing process for the medical technology industry. As the complexity of medical device design increases, MedTech Advance provides a centralized platform for Engineering,...
Heartbeats Shareholder Mr Lu Min Yong Honoured as “Global Chinese Role Model” at the 2026 Spring Festival Gala Evening
SYDNEY and BEIJING, Jan. 27, 2026 /PRNewswire/ -- Heartbeats proudly congratulates its shareholder, Lu Min Yong, on being awarded the title of "全球华人楷模" (Global Chinese Role Model) at the Global Chinese Spring Festival Gala Evening held as part of the 2026 Chinese New Year celebrations in Beijing, China. This honour recognises Mr...
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, announced that its anti-GPRC5D/BCMA/CD3 tri-specific antibody IBI3003 has received Fast Track Designation (FTD) from the U.S. Food and Drug...
TIAN RUIXIANG Holdings Ltd. Announces Receipt of Nasdaq Delisting Notification Regarding Minimum Bid Price Deficiency
BEIJING, Jan. 27, 2026 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) (the "Company" or "TRX") today announced that it had received a written notification (the "Notice") from the Listing Qualifications (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on January 20, 2026, indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the...
Dimora Medical Named Amazon Best Seller in Wound Dressings for Fourth Consecutive Year
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, has been named a 2025 Amazon Best Seller in the Wound Dressings category, marking the fourth consecutive year the brand has held this distinction. The continued recognition underscores that Dimora Medical has earned widespread trust from consumers for combining clinical-grade functionality with everyday...
Functional Medicine Malaysia: Emagene Life Academy Officially Launches with Successful “Good Gut Gathering” Workshop
KUALA LUMPUR, Malaysia, Jan. 26, 2026 /PRNewswire/ -- Emagene Life, a leading functional medicine and longevity practice in Malaysia, has officially launched the Emagene Life Academy, marking a major milestone in the advancement of functional medicine education in the region. The Academy's launch was celebrated with the successful completion of its inaugural workshop, "Good Gut Gathering," a community-focused event centred...
Picarro Appoints Haavard Oestensen Chief Commercial and Product Officer to Lead Market-Focused Growth and Launch of Fenceline Solution
SANTA CLARA, Calif., Jan. 27, 2026 /PRNewswire/ -- Picarro, Inc., a global leader in real-time emissions monitoring and advanced gas analysis solutions, today announced the appointment of Haavard Oestensen as Chief Commercial and Product Officer. In this role, Oestensen will lead Picarro's commercial and product strategy in Oil & Gas as...
BIOSeedin Winter Innovation Partnering Summit：J.P.Morgan Spotlight
SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- To enable Chinese innovative pharmaceutical companies to more efficiently connect with international resources, bioSeedin, a platform facilitating cooperation in innovative drug assets, hosted the BIOSeedin Winter Innovation Partnering Summit in San Francisco on January 11, 2026. The event centered on the "China Asset Showcase", providing an exclusive international roadshow and licensing cooperation forum...
